EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular contrast agents for post-infarct cardiac remodelling: a contemporary review

Pak Yin Lam iD, William D Watson, Ziad Mallat iD, Jason Tarkin iD

European Heart Journal - Imaging Methods and Practice · 01.01.2026 · 4 (1)

DOI: 10.1093/ehjimp/qyag019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Heart Journal - Imaging Methods and Practice, online erschienen am 29.01.2026. Verfasst von Pak Yin Lam und 3 weiteren Autor:innen. Beteiligte Einrichtung: GKT School of Medical Education, King's College London, 1/F Henriette Raphael Building, Guy's Campus, London SE1 1UL, UK. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, British Heart Foundation, National Institute for Health and Care Research Cambridge Biomedical Research Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myocardial infarction (MI) is a leading cause of mortality, affecting 3.8% of the global population under 60 years of age, and 9.5% over 60 years. Adverse post-MI remodelling is the main contributor to heart failure, conferring a three- to six-fold increase in risk of premature death. Current imaging modalities, such as nuclear imaging and magnetic resonance imaging, provide structural and functional information of the heart and identify extracellular expansion for indirect estimation of infarct size. However, they do not characterize the exact biological mechanisms involved, nor the staging of disease progression. Molecular imaging aims to visualize the underlying processes of remodelling at a molecular and cellular level, aiding more accurate prognosis and targeted treatment. Molecular tracers, such as radioisotopes and paramagnetic nanoparticles, are modified to adhere to specific molecules or cells involved in inflammation, angiogenesis, and scar formation, which can be visualized and quantitatively assessed using positron-emission tomography and magnetic resonance imaging. This article provides an overview of the pathophysiology of adverse remodelling, the latest molecular contrast agents under development, and future directions for integration into clinical practice.

Schlagwörter

Stichwörter der Autor:innen

MRIPETcardiac remodellingmolecular imagingmyocardial infarction

Autor:innen und Institutionen

  • GKT School of Medical Education, King's College London, 1/F Henriette Raphael Building, Guy's Campus, London SE1 1UL, UK.
  • Section of Cardiorespiratory Medicine, University of Cambridge, Victor Phillip Dahdaleh Heart & Lung Research Institute, Cambridge, UK.

ORCID-Profile: Pak Yin Lam, Ziad Mallat, Jason Tarkin

Förderung

  • Wellcome Trust
  • British Heart Foundation
  • National Institute for Health and Care Research Cambridge Biomedical Research Centre

Zitieren

APA

Lam, P. Y., Watson, W. D., Mallat, Z., & Tarkin, J. (2026). Molecular contrast agents for post-infarct cardiac remodelling: a contemporary review. European Heart Journal - Imaging Methods and Practice, 4(1). https://doi.org/10.1093/ehjimp/qyag019

Vancouver

Lam PY, Watson WD, Mallat Z, Tarkin J. Molecular contrast agents for post-infarct cardiac remodelling: a contemporary review. European Heart Journal - Imaging Methods and Practice. 2026;4(1). doi:10.1093/ehjimp/qyag019

BibTeX
@article{Lam2026,
  author = {Lam, Pak Yin and Watson, William D and Mallat, Ziad and Tarkin, Jason},
  title = {Molecular contrast agents for post-infarct cardiac remodelling: a contemporary review},
  journal = {European Heart Journal - Imaging Methods and Practice},
  year = {2026},
  volume = {4},
  number = {1},
  doi = {10.1093/ehjimp/qyag019}
}
Kostenlos starten →